Application of air compressor in the production of pharmaceutical intermediates
Pharmaceutical intermediates production industry background
Pharmaceutical intermediates are key raw materials in the drug synthesis process, and their quality directly affects the safety and effectiveness of the final drug. In the production process of pharmaceutical intermediates, compressed air is widely used in pneumatic transportation, reaction vessel stirring, vacuum drying, filtration and separation, etc. According to compressed air purity rating standards ISO 8573-1:2010, the production of pharmaceutical intermediates requires extremely strict purity of compressed air and needs to meet the following standards:
- Oil content: <0.01ppm
- Dust content: <0.01μm
- Dew point: ≤-20℃ (PDP)
- Exhaust pressure: 0.8MPa
Shanghai Granklin Group’s oil-free compression technology, combined with Germany’s Tüv “0” oil-free certification, has become the core equipment to ensure the production quality of pharmaceutical intermediates.
Why does pharmaceutical intermediate production require high-quality air compressors
- prevent product contamination
Residual oil will lead to a decrease in the purity of the intermediate and affect the efficacy of the final drug.ISO 8573-1:2010 Class 1It is clearly stipulated that the oil content of compressed air used in pharmaceutical production must be <0.01ppm. Only oil-free air compressors can achieve this goal through the system’s pollution-free certification. - Ensure equipment reliability
Oil mist can block pneumatic conveying pipes and stirrers, causing equipment failure. Oil-free technology can extend equipment life to more than 10,000 hours and reduce annual maintenance costs by 40%. - compliance requirements
The production of pharmaceutical intermediates must comply with GMP regulations. As a key process medium, compressed air must pass the environmental management system certification to ensure no pollution. - energy consumption optimization
Permanent magnet frequency conversion technology combined with oil-free compression reduces energy consumption by 18%-25% compared with traditional models, and has passed ISO 50001 energy management system certification.
Selection of core parameters
according to ISO 8573-1:2010 Class 1In line with the pharmaceutical industry specifications, the following parameters need to be verified:
| parameters | standard requirements | Certification support |
|---|---|---|
| oil content | <0.01ppm (laser online monitoring) | Germany Tüv “0” oil-free certification |
| dew point control | -20℃（PDP）±2℃ | quality management system certification |
| dust content | 0.01μm (H13 HEPA filter) | Product quality and safety certification certificate |
| pressure stability | ≤0.5%FS（0.6-0.8MPa） | EU CE certification |
| corrosion resistance rating | ≥IP55 (workshop humidity 80%) | environmental management system certification |
Potential risks of not using high-quality air compressors
- Product pollution loss
Oil content caused a decrease in the purity of the intermediate, and the loss from scrapping a single batch exceeded 1 million yuan. - equipment failure
Oil coke blocks pneumatic transportation pipelines (maintenance costs increase by 500,000 yuan annually). - Certification fails
If you fail the GMP review, you will lose your drug production license qualification. - legal accountability
Violation of Article 44 of the Drug Administration Law and face a fine of 2% of annual revenue.
Economic benefits of using high-quality air compressors
| Income dimension | quantitative indicators | Certification support |
|---|---|---|
| Direct cost reduction | The 75kW model saves 220,000 yuan in annual electricity bills | ISO 50001 energy management system |
| Improved yield | Intermediate pass rate +2.5% | quality management system certification |
| Maintenance cost optimization | Filter replacement frequency reduced by 65% | environmental management system certification |
| Carbon trading earnings | Annual carbon reduction is 180 tons (worth 210,000 yuan) | ISO 14064 certification |
Comparison of oilless compressors versus oilless compressors in the production of pharmaceutical intermediates
| parameters | oil-free compressor | Oiled compressor |
|---|---|---|
| oil content | <0.01ppm (real-time monitoring) | ≥0.01ppm (requires three-level filtration) |
| dew point stability | -20℃±2℃ (smart adsorption system) | -10℃±5℃ (oil interference adsorbent) |
| Average annual maintenance cost | 180,000 – 250,000 yuan | 500,000 – 800,000 yuan (oil-containing filter replacement) |
| equipment life | 10-12 Year (fully enclosed design) | 5-7 Year (caused by oil pollution corrosion) |
| compliance of | Passed CE/Tüv/GMP certification | Only meets basic industrial safety certification |
summary
Choosing high-quality air compressors for pharmaceutical intermediate manufacturers is the core decision to ensure product quality and compliance. By strictly following ISO 8573-1:2010standards and GMPRequirements that such equipment can eliminate the risk of oil pollution and achieve green and intelligent manufacturing. Leading manufacturers such as Shanghai Granklin Group are using innovative technologies certified by Germany’s Tüv “0” level to provide global pharmaceutical companies with oil-free compressed air solutions suitable for advanced processes.